Fulcrum Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fulcrum Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $8.0k | 709 | 11.31 |
| 2025-03-31 | $2.0k | 703 | 2.88 |
| 2023-06-30 | $73k | 26k | 2.85 |
| 2023-03-31 | $73k | 26k | 2.85 |
| 2022-12-31 | $108k | 15k | 7.28 |
| 2022-09-30 | $120k | 15k | 8.09 |
| 2022-06-30 | $73k | 15k | 4.90 |
| 2022-03-31 | $350k | 15k | 23.65 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas